drugset / Trial / NCT03850587
Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee
RandomizedParallel-groupDouble-blindTreatment
Summary
A Multi-center, Double-blinded, Randomized, Active-controlled, Parallel Design, phaseII Study to Investigate the Efficacy and Safety of YYC301 in Subject With Knee Osteoarthritis
Timeline
- Start
- 2018-08-30
- Primary completion
- 2020-05-12
- Completion
- 2020-09-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Celecoxib | Other / unclassified | 200 mg | — |
| Subject | Tramadol | Other / unclassified | 37.5 mg | — |
| Subject | Tramadol | Other / unclassified | 75 mg | — |
| Subject | Tramadol | Other / unclassified | 150 mg | — |